Nvidia's Forward P/E Has Actually Fallen as Its Stock Price Rose. Here's How That's Possible.

Nvidia is up ~12% YTD, yet its forward P/E has fallen to 23.2 from ~40 at end-July 2025, largely because expected EPS growth has outpaced the stock’s price gains. The article cites net income growth that has more than tripled YoY in fiscal 2027 Q1 and guidance implying ~$91B in fiscal 2027 Q2 revenue, consistent with >10% sequential sales growth, which supports higher EPS projections and a lower forward multiple. Net effect: valuation looks more compelling ahead of “solid earnings” expected late August, though it’s presented as an analytical/valuation argument rather than a new earnings print.

Analysis

The important signal is not that NVDA is “cheap”; it is that the market is being forced to raise the earnings denominator faster than price, which usually happens when near-term demand visibility improves and pricing power holds. That is constructive for sentiment, but it also means the stock is increasingly hostage to guide quality: if the next print only confirms current growth rather than re-accelerating it, the multiple can stall even with strong absolute numbers.

Second-order winners are the ecosystem names with less execution risk than the headline supplier set: TSM gets volume leverage if NVDA continues to outrun expectations, while AVGO and MRVL can benefit if AI infrastructure spend broadens beyond GPUs. The relative loser is AMD, because any evidence that NVDA’s ramp is still outrunning estimate revisions raises the bar for share gains in accelerators and reinforces a winner-take-most narrative. The broader semi ETF complex (SMH/SOXX) should still track NVDA, but index ownership means upside will be diluted unless earnings broaden out across the basket.

The contrarian point is that a lower forward P/E can be a valuation trap if consensus is baking in another year of extraordinary growth that is hard to repeat. The most likely falsifiers over the next 1-3 months are a guide that implies slower sequential growth, gross margin compression from mix, or any sign of customer digestion in hyperscale capex. Over 6-18 months, export restrictions and competitive substitution matter more than headline valuation; if either reduces NVDA’s share of AI spend, the multiple can compress even with healthy revenue growth.

Key Decisions for Investors

• Buy NVDA on post-earnings volatility only, not pre-print momentum; preferred entry is a 3%-5% pullback into late-August earnings. Risk/reward is attractive only if next-quarter revenue and GM guide both move higher; if guidance merely meets street, trim into the event.
• Express the cleaner expression via NVDA/AMD pair: long NVDA, short AMD for a 1-3 month relative-value trade. Thesis is continued share concentration in AI accelerators; invalidation would be AMD showing materially better cloud win-rates or NVDA guide disappointment.
• For options, consider a modest NVDA call spread into earnings rather than outright long delta. Use a 2-4 month tenor to capture the catalyst while capping premium at risk if the market has already priced the lower forward P/E.
• Watch SMH/SOXX for confirmation rather than initiating there first; if NVDA leads but the basket lags, that is a sign to favor single-name over ETF exposure. If SMH outperforms on broadening revision strength, rotate from NVDA into the basket.